J.P. Morgan Keeps Their Hold Rating on Waters (WAT)
In a report released today, Casey Woodring from J.P. Morgan maintained a Hold rating on Waters, with a price target of $330.00.
Valentine's Day Sale - 70% Off
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Woodring covers the Healthcare sector, focusing on stocks such as BillionToOne, Inc. Class A, Danaher, and Qiagen. According to TipRanks, Woodring has an average return of -4.4% and a 40.51% success rate on recommended stocks.
In addition to J.P. Morgan, Waters also received a Hold from Bank of America Securities’s Michael Ryskin in a report issued yesterday. However, on the same day, Barclays initiated coverage with a Buy rating on Waters (NYSE: WAT).
Based on Waters’ latest earnings release for the quarter ending September 27, the company reported a quarterly revenue of $799.89 million and a net profit of $148.92 million. In comparison, last year the company earned a revenue of $740.31 million and had a net profit of $161.5 million
Read More on WAT:
Disclaimer & DisclosureReport an Issue
- Waters price target lowered to $370 from $395 at UBS
- Waters price target lowered to $363 from $398 at Baird
- Waters price target lowered to $373 from $400 at TD Cowen
- Waters resumed with an In Line at Evercore ISI
- Maintaining Hold on Waters as BD Life Sciences Weakness and Reduced Premium Valuation Temper Near‑Term Upside
